InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Lawlor Augustine, 董事. Insider active across 3 companies, notably Catalyst Biosciences, INC.. Aggregated, 9 disclosures have been logged. Activity tracked since 1 July 2021. The latest transaction was disclosed on 13 November 2024 (X). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lawlor Augustine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
22,500 股Common StockSEC:0001104659-25-030808:0
2,136 股@ US$2.82100.0% 占其流量Common StockSEC:0001104659-24-119793:0
5,000 股Common StockSEC:0001104659-24-008418:0
24.573 股Series Y Preferred StockSEC:0001140361-23-042365:0
5,022 股@ US$20.00100.0% 占其流量Common StockSEC:0001062993-23-009600:0
1,222 股0Common StockSEC:0000914190-21-000411:0
5,839 股0Common StockSEC:0001209191-21-059429:0
1,710 股0Common StockSEC:0000914190-21-000245:0
5,542 股0Common StockSEC:0001209191-21-044690:0
9 条申报中的 9 条
About Lawlor Augustine
LAWLOR AUGUSTINE is Administrateur. He has 9 filings in total, and across the 9 most recent filings available, the reported sell amount is EUR 91044, with a period running from 2021-07-02 to 2025-04-01. His listed companies are Leap Therapeutics, INC., Catalyst Biosciences, INC. and Cardiovascular Systems Inc.
